Erik M Schlicht
Overview
Explore the profile of Erik M Schlicht including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
412
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Juran B, McCauley B, Atkinson E, Schlicht E, Bianchi J, Vollenweider J, et al.
Hepatol Commun
. 2024 Jul;
8(8).
PMID: 39023332
Background: The epigenome, the set of modifications to DNA and associated molecules that control gene expression, cellular identity, and function, plays a major role in mediating cellular responses to outside...
2.
Grant C, Juran B, Ali A, Schlicht E, Bianchi J, Hu X, et al.
Exposome
. 2023 Jan;
3(1):osac011.
PMID: 36687160
Primary sclerosing cholangitis (PSC) is a complex bile duct disorder. Its etiology is incompletely understood, but environmental chemicals likely contribute to risk. Patients with PSC have an altered bile metabolome,...
3.
Cheung A, Juran B, Schlicht E, McCauley B, Atkinson E, Moore R, et al.
Epigenomics
. 2022 Apr;
14(8):481-497.
PMID: 35473391
In this methylome-wide association study of cholestatic liver diseases (primary sclerosing cholangitis and primary biliary cholangitis), the authors aimed to elucidate changes in methylome and pathway enrichment to identify candidate...
4.
Walker D, Juran B, Cheung A, Schlicht E, Liang Y, Niedzwiecki M, et al.
Hepatol Commun
. 2021 Nov;
6(5):965-979.
PMID: 34825528
Progress in development of prognostic and therapeutic options for the rare cholestatic liver diseases, primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC), is hampered by limited knowledge of their...
5.
Ali A, Juran B, Schlicht E, Bianchi J, McCauley B, Atkinson E, et al.
BMC Gastroenterol
. 2021 Sep;
21(1):353.
PMID: 34563121
Background: Primary sclerosing cholangitis (PSC) is a rare, chronic cholestatic liver disease that often progresses to end-stage liver disease and/or the development of hepatobiliary neoplasia. Lack of prognostic tools and...
6.
Punia S, Juran B, Ali A, Schlicht E, Moore R, Sun Z, et al.
BMC Gastroenterol
. 2021 Apr;
21(1):149.
PMID: 33794792
Background: Quantification of circulating organ-specific cell-free DNA (cfDNA) provides a sensitive measure of ongoing cell death that could benefit evaluation of the cholestatic liver diseases primary biliary cholangitis (PBC) and...
7.
Mousa O, Juran B, McCauley B, Vesterhus M, Folseraas T, Turgeon C, et al.
Hepatology
. 2020 Nov;
74(1):281-295.
PMID: 33226645
Background And Aims: Altered bile acid (BA) homeostasis is an intrinsic facet of cholestatic liver diseases, but clinical usefulness of plasma BA assessment in primary sclerosing cholangitis (PSC) remains understudied....
8.
Cheung A, Gulamhusein A, Juran B, Schlicht E, McCauley B, de Andrade M, et al.
Hepatol Commun
. 2018 Jun;
2(6):676-682.
PMID: 29881819
The United Kingdom-Primary Biliary Cholangitis (UK-PBC) risk scores are a set of prognostic models that estimate the risk of end-stage liver disease in patients with PBC at 5-, 10- and...
9.
Eaton J, Vesterhus M, McCauley B, Atkinson E, Schlicht E, Juran B, et al.
Hepatology
. 2018 May;
71(1):214-224.
PMID: 29742811
Improved methods are needed to risk stratify and predict outcomes in patients with primary sclerosing cholangitis (PSC). Therefore, we sought to derive and validate a prediction model and compare its...
10.
Eaton J, McCauley B, Atkinson E, Juran B, Schlicht E, de Andrade M, et al.
J Gastroenterol Hepatol
. 2017 Mar;
32(10):1763-1768.
PMID: 28245345
Background And Aim: Primary sclerosing cholangitis (PSC) typically develops in middle-age adults. Little is known about phenotypic differences when PSC is diagnosed at various ages. Therefore, we sought to compare...